 PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multiproduct medical device company, today announced that the EsoCheckTM Esophageal Cell Collection Device with CollectProtectTM Technology, developed and marketed by its majority owned subsidiary Lucid Diagnostics Inc. Lucid, was named a Silver winner of the 2020 Edison Best New Product Awards in the MedicalDental category and Testing Solutions subcategory. After a thorough review, the Edison Awards judges recognize EsoCheck as a game-changing innovation standing out among the best new products and services launched in their category, said Frank Bonafilia, Executive Director of the Edison Awards. We are honored that the Edison Awards has recognized EsoCheck as a game-changing innovation placing it among the best new medical device products this year, said Lishan Aklog, M.D., PAVmeds Chairman and Chief Executive Officer and Lucids Executive Chairman. 